Clinical trial
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary…
NCT00457457 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00457457 |
|---|---|
| Title | Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. |
| Official title | A Multi-center, Randomized, Parallel Group, Double-blind, Placebo Controlled Proof of Concept and Dose Ranging Study With an Active Control to Assess the Efficacy and Safety/Tolerability of UK-369,003 Immediate Release (IR) and Modified Release (MR) in the Treatment of Men With Lower Urinary Tract… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | Tamsulosin, UK-369, 003 |
| Enrollment | 609 |
| Start date | May 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Apr 6, 2007 |
| Last update posted | Dec 19, 2018 |
| Countries | Australia, Belgium, Canada, Chile, Colombia, Denmark, Finland, Greece, Italy, Latvia, Lithuania, Poland and 3 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: